ctrl K

Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

32.05

1.43 (4.67%)

At close: May 02, 2025, 3:59 PM

32.00

-0.14%

After-hours: May 02, 2025, 04:36 PM EDT

Bright Minds Biosciences Ratios and Metrics

Financials in CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
PE Ratio	-2.43	-1.1	-1.39	-9.4	-95.77	-193.9
PEG Ratio	0.04	0.02	-0.05	-0.01	-0.18	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	1.23	1.22	1.97	4.19	63.09	359.80
P/FCF Ratio	-3.69	-1.15	-1.53	-11.11	-159.53	-1.09K
P/OCF Ratio	-3.69	-1.15	-1.53	-11.11	-159.53	-1.09K
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.02	0.01	0.01	n/a	n/a	n/a
Quick Ratio	11.32	24.26	8.11	31.38	5.82	2.18
Current Ratio	11.32	24.26	8.11	31.38	5.82	2.18
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	-0.51	-1.12	-1.42	-0.45	-0.66	-1.86
Return on Assets	-0.46	-1.07	-1.24	-0.43	-0.55	-1.44
Return on Invested Capital	-0.46	-1.08	-1.38	-0.44	-0.65	-1.86
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a